U.S. Pharma Stock News

How Warner Bros. Discovery Stock Has Been Trading Recently Warner Bros. Discovery (WBD) has seen mixed share performance recently, with a slight 1 day decline, modest weakness over the past week, and negative returns over the month and past 3 months. Over a longer horizon, the stock shows a small positive total return year to date and over the past year. However, the 5 year total return remains negative, which highlights the importance of your investment timeframe. See our latest analysis for...

If you are wondering whether Clearway Energy's share price still offers value after a strong run, the key is understanding what the current market price might already be factoring in. The stock last closed at US$39.64, with returns of 1.2% over 7 days, 12.7% over 30 days, 23.4% year to date, 68.3% over 1 year, 58.3% over 3 years and 94.3% over 5 years. This raises the question of how much of the story is already reflected in the valuation. Recent news around Clearway Energy has focused on...

Investors may be wondering whether Sprouts Farmers Market is still priced attractively after recent volatility, or if the easy value has already been taken off the table. The stock closed at US$77.12, with returns of 0% over 7 days, a 3.9% decline over 30 days, a 4.4% decline year to date, a 46.7% decline over 1 year, but gains of 123.9% over 3 years and 182.9% over 5 years. Recent attention on Sprouts Farmers Market has focused on its longer term share price track record compared with more...

Why Coeur Mining is on investors’ radar today Coeur Mining (CDE) is drawing fresh attention after a recent move in its share price, with the stock gaining 2.2% over the past day but showing a 16.1% decline over the past month. See our latest analysis for Coeur Mining. That 2.2% 1 day share price gain comes after a 16.1% 30 day share price decline. Coeur Mining still carries an 8.3% year to date share price return and a very large 1 year total shareholder return of 295%. This suggests longer...

If you are wondering whether Intuitive Surgical at around US$452 a share still offers good value or if most of the opportunity has already been priced in, you are not alone. The stock is currently around US$452.47, with a 7 day return of a 1.8% decline, a 30 day return of a 7.7% decline, a year to date return of a 19.5% decline, a 1 year return of a 1.1% decline, and a 3 year return of 72.2% and a 5 year return of 70.9%. Recent coverage has focused on Intuitive Surgical's position in robotic...

Wondering if Titan America at around US$14.98 is still offering value or if the easy gains are behind it? This breakdown will help you frame what the current share price might actually represent. The stock is flat over the last 7 days, sits about 6.7% below its 30 day level and is down 10.4% year to date, yet it has returned 35.7% over the past 12 months. This can leave investors asking what the market is really pricing in. Recent attention on Titan America has focused on how it fits into...

In 2025, nVent Electric benefited from surging data center demand for liquid cooling solutions and a recent acquisition that supported higher revenue, drawing praise in Mairs & Power Small Cap Fund’s fourth-quarter investor letter. The company also attracted increased hedge fund interest and favorable analyst attention, underscoring how its exposure to AI-driven infrastructure resonated with institutional investors. We’ll now examine how this stronger AI data center demand narrative may...

Sieve Capital LLC has gone public with a call for Americold Realty Trust (COLD) to replace its chairman and review options, including a potential sale, citing governance concerns and weak shareholder returns. See our latest analysis for Americold Realty Trust. The activist push arrives after a weak run for Americold, with the latest share price at $11.42 and a 1-year total shareholder return of about a 30% decline. This has compounded into deeper losses over 3 and 5 years, which suggests...

Hancock Whitney Corporation recently reported that its Q4 2025 earnings per share rose 8% and that it increased its common stock cash dividend for Q1 2026, payable on March 16, 2026 to shareholders of record on March 5, 2026. The company also plans to hire 50 new associates, a move that signals management’s confidence in expanding its banking and wealth operations. Next, we’ll explore how Hancock Whitney’s dividend increase shapes the existing investment narrative built around earnings...

In its latest results, WillScot Holdings reported a 13% year-over-year decline in EBITDA, a similar drop in units on rent, and wrote off about 15% of its rental fleet, underscoring mounting financial and operational pressure. These fleet impairments and signs of tougher competition, particularly from United Rentals, point to a business mix tilting toward smaller, less profitable segments. Against this backdrop of fleet write-offs and weakening core metrics, we will assess how the news...

ANI Pharmaceuticals recently reported that results from its Phase 4 NEW DAY clinical trial of ILUVIEN for diabetic macular edema were published in Ophthalmology, the journal of the American Academy of Ophthalmology, further detailing efficacy, safety, and extensive adverse event data for this intravitreal corticosteroid implant. The peer-reviewed publication raises ILUVIEN’s profile within the retina community, potentially influencing physician treatment choices and payer discussions by...

Why NBT Bancorp Stock Is on Investors’ Radar NBT Bancorp (NBTB) has drawn attention after recent share moves, with the stock showing positive returns over the past month and past 3 months, prompting investors to reassess its valuation and fundamentals. See our latest analysis for NBT Bancorp. At a share price of $43.99, NBT Bancorp’s recent 1 month share price return of 5.67% and 1 year total shareholder return of 17.80% suggest momentum has been building rather than fading, as investors...

Amazon.com (NasdaqGS:AMZN) has reached an updated agreement with the U.S. Postal Service that limits reductions in Amazon packages handled by USPS to 20%. The revised pact preserves the majority of Amazon volumes flowing through the postal network, easing prior concerns about a sharper pullback. The agreement reduces operational risk for both Amazon and USPS, which has relied heavily on Amazon parcel traffic. For investors watching Amazon at a share price of $213.77, this development...

CME Group, the world’s leading derivatives marketplace, has moved to expand its regulated cryptocurrency derivatives lineup by launching Avalanche (AVAX) and Sui (SUI) futures, including micro contracts, and making its crypto futures and options tradable 24/7 from late May, following regulatory approval. This broadening of CME’s crypto coverage into newer layer-1 tokens, combined with round-the-clock trading, deepens its role as a regulated entry point for institutional and retail digital...

Spyre Therapeutics recently reported that it completed enrollment ahead of schedule for the rheumatoid arthritis cohort in its Phase 2 SKYWAY trial of SPY072, while CEO Cameron Turtle sold 15,000 shares under a pre-arranged Rule 10b5-1 trading plan and new employees received stock option inducement grants. This combination of faster-than-planned clinical progress and ongoing insider and employee equity activity highlights how drug development milestones and leadership incentives are evolving...

Booking Holdings (BKNG) has just completed a 25 for 1 stock split, cutting its share price from above US$4,000 to around US$170, as volatile trading and geopolitical travel concerns put the stock in focus. See our latest analysis for Booking Holdings. The split-adjusted share price of around US$173.41 sits near recent lows, with a 90 day share price return of a 20.39% decline and a year-to-date share price return of an 18.56% decline, even as the 5 year total shareholder return of 83.68%...

Why Brookfield Wealth Solutions is on investors’ radar today Brookfield Wealth Solutions (BNT) has been drawing attention after a period where the share price shows mixed returns across different time frames. This has prompted closer scrutiny of its business mix and current valuation. See our latest analysis for Brookfield Wealth Solutions. The latest 1 day share price return of a 0.4% decline and 90 day share price return of a 12% decline contrast with a 1 year total shareholder return of...

Albertsons Companies (ACI) shares are reacting to expectations that upcoming fiscal Q4 results could show adjusted EBITDA and identical sales ahead of market forecasts, with management anticipated to reiterate growth guidance for fiscal 2026. See our latest analysis for Albertsons Companies. The latest move backs up a 12.18% 90 day share price return and a 4.28% year to date share price gain, although the 1 year total shareholder return decline of 11.12% shows longer term momentum has been...

AtaiBeckley (ATAI) recently posted quarterly results that surpassed market expectations, reporting an earnings per share loss of US$0.06 and revenue of US$1.07m, along with continued progress across its mental health treatment pipeline. See our latest analysis for AtaiBeckley. AtaiBeckley’s recent earnings surprise and pipeline updates have come alongside a 13.24% 7 day share price return and 13.57% 30 day share price return, while the 1 year total shareholder return of about 7x points to...

In recent weeks, Alliant Energy announced a US$1.00 billion at-the-market equity offering to fund data center and AI/cloud-related infrastructure, alongside governance changes such as a mandatory director retirement age of 70 and a target of 75% independent board representation. The same initiatives have drawn rising environmental and community opposition in Wisconsin and Iowa, highlighting that Alliant’s push into digital infrastructure could reshape both its growth profile and its...

Acadia Pharmaceuticals has recently confirmed that DAYBUE STIX, a dye- and preservative-free powder formulation of trofinetide for Rett syndrome in patients aged two and older, is now broadly available in the United States following its FDA approval in December 2025. The addition of a bioequivalent, more flexible powder option that aligns with expert recommendations for real-world trofinetide use could strengthen DAYBUE’s role in Rett syndrome care and deepen Acadia’s engagement with this...

Confirmation that TMC the metals (TMC) has a complete consolidated deep sea mining application with U.S. regulators, along with new NOAA rules that can shorten permitting timelines, has pushed this early stage minerals story back into focus. See our latest analysis for TMC the metals. The confirmation of TMC's complete U.S. mining application and the new NOAA rules arrive after a sharp share price reset, with a 30 day share price return of a 19.9% decline and a 90 day share price return of a...

Enovix recently reported quarterly results that topped revenue and adjusted loss expectations while also outlining first-quarter guidance, and reports emerged of a potential partnership with Meta-Bounds to boost battery life for lightweight AR glasses by an estimated 61%. This possible collaboration underscores how Enovix’s battery technology may fit into emerging augmented reality devices, complementing its improving, though still loss-making, financial profile. Now we’ll examine how the...

What Enova International (ENVA) investors are watching now Enova International (ENVA) has drawn fresh attention as its recent share performance contrasts sharply between time frames, with a modest move over the past month alongside a 14% decline in the past 3 months. See our latest analysis for Enova International. At a share price of $138.77, Enova International’s recent 5.7% 7 day share price return contrasts with a 14.3% year to date share price decline. The 1 year total shareholder return...